Skip to main content

Advertisement

Log in

A Single Institution Retrospective Comparison Study of Locoregional Recurrence After Accelerated Partial Breast Irradiation Using External Beam Fractionation Compared with Whole Breast Irradiation with 8 Years of Follow-Up

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Accelerated partial breast irradiation (APBI) was developed to address disadvantages of overall treatment time and potentially unnecessary radiation associated with whole breast irradiation (WBI). We report updated results of our single institution study using an external beam APBI regimen with a median follow-up of 8 years.

Methods

A total of 290 APBI patients with AJCC Stage 0–II breast cancer were compared with 290 WBI patients with matched tumor characteristics. Toxicities were scored based on the Common Terminology Criteria for Adverse Events (CTCAE v3.0). Cox regression models were used to predict likelihood of freedom from ipsilateral failure.

Results

Median follow-up was 8 years in the APBI group and 7.5 years in the WBI group. In the APBI group, there were 18 (6.2%) ipsilateral breast tumor recurrence (IBTR), 13 (72%) had elsewhere failures (EF), and 5 (28%) had local failures (LF) with a median time to failure of 64.1 months. In the WBI group, there were three (1.0%) IBTR; one (33%) was an EF and two (67%) were LF with a median time to failure of 91 months. APBI was 4.6 times more likely (hazard ratio 4.57, 95% confidence interval 1.3–16.2, p = 0.02) to have an IBTR than WBI after adjusting for age, tumor size, histology, grade, and estrogen receptor status. Fatigue, erythema, and desquamation toxicities were significantly less in the APBI group then the WBI group.

Conclusions

IBTR rates were higher in external beam APBI group compared with WBI, but APBI had fewer toxicities. Clinicians must weigh the risks and benefits of APBI when making a recommendation for partial breast irradiation after lumpectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Touboul E, Buffat L, Belkacemi, et al. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys. 1999;43(1):25-38.

    Article  CAS  PubMed  Google Scholar 

  2. Fortin A, Larochelle M, Laverdiere J, et al. Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol. 1999;17(1):101-9.

    Article  CAS  PubMed  Google Scholar 

  3. Yeboa D, Evans S. Contemporary breast radiotherapy and cardiac toxicity. Sem Radiat Oncol. 2016;26:71-8.

    Article  Google Scholar 

  4. Gradishar W, Anderson B, Balassanian R, et al. Invasive breast cancer version 12016, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2016;14:324–54.

    Article  Google Scholar 

  5. Chen P, Wallace M, Mitchell C, et al. Four-Year efficacy, cosmesis, and toxicity using three-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2010;76(4):991–7.

    Article  PubMed  Google Scholar 

  6. Shaitelman S, Lin HY, Smith BD, et al. Practical implications of the publication of consensus guidelines by the American Society for Radiation Oncology: accelerated partial breast irradiation and the National Cancer Data Base. Int J Radiat Oncol Biol Phys. 2016;94(2):338–48.

    Article  PubMed  Google Scholar 

  7. Vicini F, Winter K, Wong J, et al. Initial efficacy results of RTOG 0319: three-dimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/II breast carcinoma. Int J Radiat Oncol Biol Phys. 2010;77(4):1120–7.

    Article  PubMed  Google Scholar 

  8. Whelan T, Pignol JP, Levine M, et al. Long-term results of hypofractioned radiation therapy for breast cancer. N Engl J Med. 2010;362(6):513–20.

    Article  CAS  PubMed  Google Scholar 

  9. Shaikh A, Lacombe M, Du H, Raghavan V, Nanda R, Bloomer W. Accelerated partial breast irradiation using once-daily fractionation: analysis of 312 cases with four years median follow-up. Radiat Oncol. 2012;7:17.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Vicini F, Beitsch P, Quiet C, et al. Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2010;79(3):808–17.

    Article  PubMed  Google Scholar 

  11. Polgar C, Fodor J, Major T, et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma—5-year results of a randomized trial. Int J Radiat Oncol Biol Phys. 2007;69(3):694–702.

    Article  PubMed  Google Scholar 

  12. Pashtan I, Recht A, Ancukiewicz M, et al. External beam accelerated partial-breast irradiation using 32 GY in 8 twice-daily fractions: 5-year results of a prospective study. Int J Radiat Oncol Biol Phys. 2012;84(3):271–7.

    Article  Google Scholar 

  13. Liss A, Merav A, Ben-David, M, et al. Decline of cosmetic outcomes following accelerated partial breast irradiation using intensity modulated radiation therapy: results of a single-institution prospective clinical trial. Int J Radiat Oncol Biol Phys. 2014;89(1):96–102.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Horst K, Fasola C, Ikeda D, Daniel B, Ognibene G, Goffinet D, Dirbas F. Five-year results of a prospective clinical trial investigating accelerated partial breast irradiation using 3D conformal radiotherapy after lumpectomy for early stage breast cancer. Breast. 2016;28:178–83.

    Article  PubMed  Google Scholar 

  15. Rabinovitch R, Moughan J, Vicini F, et al. Long-term update of NRG Oncology RTOG 0319: a Phase 1 and 2 trial to evaluate 3-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I and II breast carcinoma. Int J Radiat Oncol Biol Phys. 2016;96(5):1054–9.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Polgar C, Fodor J, Major T, Sulyok Z, Kasler M. Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. Radiother Oncol. 2013;108(2):197–202.

    Article  PubMed  Google Scholar 

  17. Hattangadi J, Powell S, MacDonald S, et al. Accelerated partial breast irradiation with low-dose-rate interstitial implant brachytherapy after wide local excision: 12-year outcomes from a prospective trial. Int J Radiat Oncol Biol Phys. 2012;83(3):791–800.

    Article  PubMed  Google Scholar 

  18. White J, Winter K, Kuske R, et al. Long-term outcome from RTOG 9517: A phase I/II study of accelerated partial breast irradiation (APBI) with multicatheter brachytherapy (MCT) following lumpectomy for early-stage breast cancer. J Clin Oncol. 2012;30:147.

    Article  Google Scholar 

  19. Kamrava M, Kuske R, Anderson B, et al. Outcomes of breast cancer patients treated with accelerated partial breast irradiation via multicatheter interstitial brachytherapy: the pooled registry of multicatheter interstitial sites (PROMIS) experience. Ann Surg Oncol. 2015;22(3):404–11.

    Article  Google Scholar 

  20. Jawad M, Shah C, Wilkinson J, et al. Seven-year outcomes following accelerated partial breast irradiation stratified by ASTRO Consensus Groupings. Am J Clin Oncol. 2015. doi:10.1097/COC.0000000000000190

  21. Choi Y, Shin Y, Song Y. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer. World J Surg Oncol. 2016;14(1):126.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Julian T, Costantino J, Vicini F, et al. Early toxicity results with 3-D conformal external beam therapy (CEBT) from the NSABP B-39/RTOG 0413 accelerated partial breast irradiation (APBI) trial. Int J Radiat Oncol Biol Phys. 2011;81(2):S7.

    Article  Google Scholar 

  23. Vaidya J, Wenz F, Bulsara M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomized trial. Lancet. 2014;383:603–13.

    Article  PubMed  Google Scholar 

  24. Beitsch P, Wilkinson J, Vicini F, et al. Tumor bed control with balloon-based accelerated partial breast irradiation: incidence of true recurrences versus elsewhere failures in the American Society of Breast Surgery MammoSite Registry Trial. Ann Surg Oncol. 2012;19(10):3165–70.

    Article  PubMed  Google Scholar 

Download references

Disclosure

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Katharine Yao MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shah, S., Kyrillos, A., Kuchta, K. et al. A Single Institution Retrospective Comparison Study of Locoregional Recurrence After Accelerated Partial Breast Irradiation Using External Beam Fractionation Compared with Whole Breast Irradiation with 8 Years of Follow-Up. Ann Surg Oncol 24, 2935–2942 (2017). https://doi.org/10.1245/s10434-017-5953-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-017-5953-9

Keywords

Navigation